New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
07:39 EDTCLDXCelldex CDX-1127 data positive, says Oppenheimer
After analyzing ASCO abstracts, Oppenheimer thinks the data indicated that Celldex's CDX-1127 is well-tolerated and capable of inducing an immune response. The firm keeps an Outperform rating on the stock.
News For CLDX From The Last 14 Days
Check below for free stories on CLDX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CLDX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use